期刊文献+

Spatiotemporal control of CRISPR/Cas9 gene editing 被引量:1

原文传递
导出
摘要 The clustered regularly interspaced short palindromic repeats(CRISPRJ/associated protein 9(CRISPR/Cas9)gene editing technology,as a revolutionary breakthrough in genetic engineering,offers a promising platform to improve the treatment of various genetic and infectious diseases because of its simple design and powerful ability to edit different loci simultaneously.However,failure to conduct precise gene editing in specific tissues or cells within a certain time may result in undesirable consequences,such as serious off-target effects,representing a critical challenge for the clinical translation of the technology.Recently,some emerging strategies using genetic regulation,chemical and physical strategies to regulate the activity of CRISPR/Cas9 have shown promising results in the improvement of spatiotemporal controllability.Herein,in this review,we first summarize the latest progress of these advanced strategies involving cell-specific promoters,small-molecule activation and inhibition,bioresponsive delivery carriers,and optical/thermal/ultrasonic/magnetic activation.Next,we highlight the advantages and disadvantages of various strategies and discuss their obstacles and limitations in clinical translation.Finally,we propose viewpoints on directions that can be explored to further improve the spatiotemporal operability of CRISPR/Cas9.
出处 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2021年第7期2088-2105,共18页 信号转导与靶向治疗(英文)
基金 This work was supported by the National Key Research and Development Program of China(2019YFA0111300,2016YFE0117100) the Guangdong Provincial Science and Technology Program(International Scientific Cooperation,2018A050506035) the National Natural Science Foundation of China(51903256,21907113,21875289,U1501243) the Science and Technology Program of Guangzhou(202102010225,201704020016) the Guangdong Provincial Pearl River Talents Program(2019QN01Y131) the Thousand Talents Plan,the Guangdong-Hong Kong Joint Innovation Project(2016A050503026) the Major Project on the Integration of Industry,Education and Research of Guangzhou City(201704030123) the Guangdong Innovative and Entrepreneurial Research Team Program(2013S086) partially supported by grants from National Research Foundation,Republic of Korea(2015K1A1A2032163,2018K1A4A3A01064257,2018R1A2B3003446).
  • 相关文献

参考文献9

二级参考文献35

  • 1Spitz F, Furlong EE. Transcription factors: from enhancerbinding to developmental control. Nat Rev Genet 2012; 13:613-626.
  • 2Blancafort P, Segal D J, Barbas CF 3rd. Designing transcription factor architectures for drug discovery. Mol Pharmacol 2004; 66:1361-1371.
  • 3Sera T. Zinc-finger-based artificial transcription factors and their applications. Adv Drug Deliv Rev 2009; 61:513-526.
  • 4Beerli RR, Segal D J, Dreier B, Barbas CF 3rd. Toward control- ling gene expression at will: specific regulation of the erbB- 2/HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks. Proc Natl Acad Sci USA 1998; 95:14628-14633.
  • 5Beerli RR, Dreier B, Barbas CF 3rd. Positive and negative regulation of endogenous genes by designed transcription fac- tors. Proc NatI Acad Sci USA 2000; 97:1495-1500.
  • 6Zhang F, Cong L, Lodato S, Kosuri S, Church GM, Arlotta P. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat Biotechnol 2011; 29:149-153.
  • 7Moscou M J, Bogdanove AJ. A simple cipher governs DNA recognition by TAL effectors. Science 2009; 326:1501.
  • 8Boch J, Scholze H, Schornack S, et al. Breaking the code of DNA binding specificity of TAL-type IIl effectors. Science 2009; 326:1509-1512.
  • 9Maeder ML, Linder S J, Reyon D, et al. Robust, synergistic regulation of human gene expression using TALE activators. Nat Methods 2013; 10:243-245.
  • 10Perez-Pinera P, Ousterout DG, Brunger JM, et al. Synergistic and tunable human gene activation by combinations of syn- thetic transcription factors. Nat Methods 2013; 10:239-242.

共引文献96

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部